Business

Former Portugal State Secretary of Health Joins Greater Cannabis Company’s European Partner, Symtomax

Former Portugal State Secretary of Health Joins Greater Cannabis Company’s European Partner, Symtomax.

articleGreater Cannabis Co Inc.October 21, 20194/company/greater-cannabis-company-inc/news/former-portugal-state-secretary-of-health-joins-greater-cannabis-companys-european-partner-symtomax
Former Portugal State Secretary of Health Joins Greater Cannabis Company’s European Partner, Symtomax

About this update from Greater Cannabis Co Inc.

[{"type":"text","content":"\n BALTIMORE, MD, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Greater Cannabis Company (OTCQB: GCAN), a market leader and innovator in the development and commercialization of cannabinoid delivery systems, is proud to announce that its European-based partner Symtomax, has appointed former Portugal State Secretary of Health to its board of directors. Symtomax currently owns one of the largest legal cannabis cultivation areas in Europe, with a planned production facility site in Portugal totaling 1,830,000 square meters. In addition to its 40 years in medical cannabis, it has extensive international experience in operations, capital markets, corporate finance, law, and healthcare services. Symtomax recently appointed Dr. Eurico Castro Alves, former State Secretary for Health and President of Portugal’s health regulator Infarmed as director of Symtomax. The appointment highlights Symtomax’s plans to grow the company into a major player in the European Medical Cannabis market. “We welcome Dr Eurico. Like Symtomax, he is passionate about healthcare. His appointment brings experience and unique expertise at the highest level, and we are delighted that such a recognised member in the International healthcare community has joined us. Symtomax will continue to evolve and lead the company forward in this fast moving and growing market place, and this appointment is yet another commitment from us on this journey”, said Symtomax Chairman Paul Segal. Eurico said of his appointment, “I am delighted to have joined Symtomax and look forward to further assisting the business on a strategic level as well as pushing the company forward on a technical front.” Dr. Eurico graduated in Medicine by the Faculty of Medicine of Porto University with a specialty in General Surgery. He completed his General Surgery training at the Southern Illinois University Medical School and at the Cook County Hospital of Chicago in Illinois USA. He obtained the degree of Instructor in Advanced Trauma Life Support by the trauma committee of the State of Illinois. Dr. Eurico was also the former chairman of the Infarmed Board of Directors, National Authority for Medicines and Health Products, IP, during which the creation of SiNATS (National Health Technology Assessment System) and Farmed (Forum of Regulatory Agencies of Lusophone Space Countries)...

More updates from Greater Cannabis Co Inc.